Acadia Healthcare (NASDAQ:ACHC) Hits New 52-Week High - Here's What Happened

Key Points

• Shares of Acadia Healthcare hit a new 52-week high intraday at $28.49 (last $27.81) on Tuesday, though the stock later traded down about 2.2% on the session with volume near 259,929 shares.
• Wall Street sentiment is mixed: the consensus rating is Hold with an average target of $22.65, while some firms (RBC, TD Cowen) have recently raised targets to $28–$30 and coverage splits 7 Buy / 7 Hold / 2 Sell.
• Acadia beat Q earnings and revenue (EPS $0.07 vs $0.03 estimate; revenue $821.5M vs $800.1M) and gave FY2026 guidance of $1.30–$1.55 EPS, but it still reports a negative net margin (~33%) and a negative PE.

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) reached a new 52-week high during mid-day trading on Tuesday . The company traded as high as $28.49 and last traded at $27.8140, with a volume of 259929 shares. The stock had previously closed at $28.15.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on ACHC shares. Royal Bank Of Canada upped their target price on Acadia Healthcare from $17.00 to $28.00 and gave the stock an "outperform" rating in a report on Thursday, February 26th. Weiss Ratings restated a "sell (d)" rating on shares of Acadia Healthcare in a research note on Wednesday, January 21st. Zacks Research upgraded Acadia Healthcare from a "strong sell" rating to a "hold" rating in a research note on Thursday, March 5th. Raymond James Financial restated an "outperform" rating and issued a $25.00 target price on shares of Acadia Healthcare in a research note on Thursday, February 26th. Finally, TD Cowen raised their target price on Acadia Healthcare from $24.00 to $30.00 and gave the company a "buy" rating in a research note on Tuesday. Seven equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $22.65.

Acadia Healthcare Trading Down 2.2%

The stock has a 50 day moving average price of $23.80 and a 200 day moving average price of $19.06. The company has a market cap of $2.53 billion, a PE ratio of -2.26, a PEG ratio of 9.25 and a beta of 0.71. The company has a current ratio of 1.55, a quick ratio of 1.55 and a debt-to-equity ratio of 1.27.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its earnings results on Wednesday, February 25th. The company reported $0.07 EPS for the quarter, topping the consensus estimate of $0.03 by $0.04. Acadia Healthcare had a positive return on equity of 6.53% and a negative net margin of 33.29%.The business had revenue of $821.46 million for the quarter, compared to the consensus estimate of $800.10 million. During the same period in the previous year, the company posted $0.64 earnings per share. The company's revenue for the quarter was up 6.1% compared to the same quarter last year. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. Sell-side analysts predict that Acadia Healthcare Company, Inc. will post 1.48 EPS for the current fiscal year.

Hedge Funds Weigh In On Acadia Healthcare

A number of hedge funds have recently added to or reduced their stakes in the company. Goldman Sachs Group Inc. lifted its position in Acadia Healthcare by 417.8% in the 4th quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company's stock valued at $67,099,000 after acquiring an additional 3,815,471 shares in the last quarter. Jefferies Financial Group Inc. purchased a new position in shares of Acadia Healthcare in the fourth quarter worth $47,960,000. Wellington Management Group LLP lifted its holdings in shares of Acadia Healthcare by 24.9% during the fourth quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company's stock valued at $167,077,000 after purchasing an additional 2,350,760 shares in the last quarter. Vaughan Nelson Investment Management L.P. purchased a new stake in shares of Acadia Healthcare during the first quarter valued at $43,017,000. Finally, Invenomic Capital Management LP increased its holdings in Acadia Healthcare by 71.0% in the 4th quarter. Invenomic Capital Management LP now owns 3,312,043 shares of the company's stock worth $46,998,000 after buying an additional 1,375,647 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc NASDAQ: ACHC is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.